184 related articles for article (PubMed ID: 20047920)
1. Pradimicin S, a highly soluble nonpeptidic small-size carbohydrate-binding antibiotic, is an anti-HIV drug lead for both microbicidal and systemic use.
Balzarini J; François KO; Van Laethem K; Hoorelbeke B; Renders M; Auwerx J; Liekens S; Oki T; Igarashi Y; Schols D
Antimicrob Agents Chemother; 2010 Apr; 54(4):1425-35. PubMed ID: 20047920
[TBL] [Abstract][Full Text] [Related]
2. Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus.
Balzarini J; Van Laethem K; Daelemans D; Hatse S; Bugatti A; Rusnati M; Igarashi Y; Oki T; Schols D
J Virol; 2007 Jan; 81(1):362-73. PubMed ID: 17050611
[TBL] [Abstract][Full Text] [Related]
3. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
[TBL] [Abstract][Full Text] [Related]
4. Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: implications for further preclinical drug development.
François KO; Auwerx J; Schols D; Balzarini J
Mol Pharmacol; 2008 Aug; 74(2):330-7. PubMed ID: 18474667
[TBL] [Abstract][Full Text] [Related]
5. Characterization and carbohydrate specificity of pradimicin S.
Shahzad-ul-Hussan S; Ghirlando R; Dogo-Isonagie CI; Igarashi Y; Balzarini J; Bewley CA
J Am Chem Soc; 2012 Aug; 134(30):12346-9. PubMed ID: 22788706
[TBL] [Abstract][Full Text] [Related]
6. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1.
Hoorelbeke B; Xue J; LiWang PJ; Balzarini J
PLoS One; 2013; 8(5):e64132. PubMed ID: 23741304
[TBL] [Abstract][Full Text] [Related]
7. Role of cations in the interaction of pradimicins with HIV-1 envelope gp120.
Hoorelbeke B; Kim Y; Oki T; Igarashi Y; Balzarini J
Curr Top Med Chem; 2013 Aug; 13(16):1907-15. PubMed ID: 23895096
[TBL] [Abstract][Full Text] [Related]
8. The phthalocyanine prototype derivative Alcian Blue is the first synthetic agent with selective anti-human immunodeficiency virus activity due to its gp120 glycan-binding potential.
François KO; Pannecouque C; Auwerx J; Lozano V; Pérez-Pérez MJ; Schols D; Balzarini J
Antimicrob Agents Chemother; 2009 Nov; 53(11):4852-9. PubMed ID: 19721061
[TBL] [Abstract][Full Text] [Related]
9. Multivalent benzoboroxole functionalized polymers as gp120 glycan targeted microbicide entry inhibitors.
Jay JI; Lai BE; Myszka DG; Mahalingam A; Langheinrich K; Katz DF; Kiser PF
Mol Pharm; 2010 Feb; 7(1):116-29. PubMed ID: 20014858
[TBL] [Abstract][Full Text] [Related]
10. Profile of resistance of human immunodeficiency virus to mannose-specific plant lectins.
Balzarini J; Van Laethem K; Hatse S; Vermeire K; De Clercq E; Peumans W; Van Damme E; Vandamme AM; Bölmstedt A; Schols D
J Virol; 2004 Oct; 78(19):10617-27. PubMed ID: 15367629
[TBL] [Abstract][Full Text] [Related]
11. Strain-Dependent Activation and Inhibition of Human Immunodeficiency Virus Entry by a Specific PF-68742 Stereoisomer.
Zhao C; Princiotto AM; Nguyen HT; Zou S; Zhao ML; Zhang S; Herschhorn A; Farrell M; Pahil K; Melillo B; Sambasivarao SV; Abrams C; Smith AB; Madani N; Sodroski J
J Virol; 2019 Nov; 93(21):. PubMed ID: 31391272
[TBL] [Abstract][Full Text] [Related]
12. Lineage-Specific Differences between the gp120 Inner Domain Layer 3 of Human Immunodeficiency Virus and That of Simian Immunodeficiency Virus.
Ding S; Medjahed H; Prévost J; Coutu M; Xiang SH; Finzi A
J Virol; 2016 Nov; 90(22):10065-10073. PubMed ID: 27535053
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
Keller PW; Morrison O; Vassell R; Weiss CD
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
[TBL] [Abstract][Full Text] [Related]
14. HIV gp120 H375 is unique to HIV-1 subtype CRF01_AE and confers strong resistance to the entry inhibitor BMS-599793, a candidate microbicide drug.
Schader SM; Colby-Germinario SP; Quashie PK; Oliveira M; Ibanescu RI; Moisi D; Mespléde T; Wainberg MA
Antimicrob Agents Chemother; 2012 Aug; 56(8):4257-67. PubMed ID: 22615295
[TBL] [Abstract][Full Text] [Related]
15. Microvirin, a novel alpha(1,2)-mannose-specific lectin isolated from Microcystis aeruginosa, has anti-HIV-1 activity comparable with that of cyanovirin-N but a much higher safety profile.
Huskens D; Férir G; Vermeire K; Kehr JC; Balzarini J; Dittmann E; Schols D
J Biol Chem; 2010 Aug; 285(32):24845-54. PubMed ID: 20507987
[TBL] [Abstract][Full Text] [Related]
16. The role of N-glycans of HIV-1 gp41 in virus infectivity and susceptibility to the suppressive effects of carbohydrate-binding agents.
Mathys L; Balzarini J
Retrovirology; 2014 Dec; 11():107. PubMed ID: 25499264
[TBL] [Abstract][Full Text] [Related]
17. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
18. A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
Xiong S; Borrego P; Ding X; Zhu Y; Martins A; Chong H; Taveira N; He Y
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795437
[TBL] [Abstract][Full Text] [Related]
19. Interaction of HIV-1 with dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-expressing cells is influenced by gp120 envelope modifications associated with disease progression.
Nabatov AA; van Montfort T; Geijtenbeek TB; Pollakis G; Paxton WA
FEBS J; 2006 Nov; 273(21):4944-58. PubMed ID: 17010165
[TBL] [Abstract][Full Text] [Related]
20. Differences in the mannose oligomer specificities of the closely related lectins from Galanthus nivalis and Zea mays strongly determine their eventual anti-HIV activity.
Hoorelbeke B; Van Damme EJ; Rougé P; Schols D; Van Laethem K; Fouquaert E; Balzarini J
Retrovirology; 2011 Feb; 8(1):10. PubMed ID: 21314946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
